Skip to content

Study of efficacy injection tuberculin in the treatment of warts

A comparison study of efficacy intralesional injection of tuberculin antigen and placebo in the treatment of multiple common warts

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015080323486N1
Enrollment
54
Registered
2015-12-02
Start date
2014-09-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple common warts. Viral warts

Interventions

Intervention 1: Intervention group:Injection of 0.1 ml PPD antigen into the largest one of warts at one week intervals for a maximum of six treatments. Intervention 2: Control groups:Injection of 0.1
Treatment - Drugs
Intervention group:Injection of 0.1 ml PPD antigen into the largest one of warts at one week intervals for a maximum of six treatments
Control groups:Injection of 0.1 ml normal saline into the largest one of the warts at one-week intervals for a maximum of six treatments.

Sponsors

Ahvaz Jundishapur University of Medical Sciences, Vice chancellor for research
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 75 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Patients with multiple common warts with past history of BCG vaccination or positive tuberculin test PPD greater than 5 millimeter or obviously scar in the upper left arm, Multiple warts equally or more than three wart. Exclusion criteria: Pregnancy or lactation, Immunosuppressive patients, Past history of TB disease, Sever reaction such as anaphylaxis to tuberculin antigen, Any generalized dermatitis, receiving other treatments for wart, receiving first and second generation anti TB drugs.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Size and number of wart. Timepoint: at start of the study and at each episode of treatment. Method of measurement: measurement diameter of wart with ruler and by photographic comparison.

Secondary

MeasureTime frame
Side effect. Timepoint: at each treatment session. Method of measurement: history and physical examination.;Recurrence of wart. Timepoint: Every two months for 6 months after complete response. Method of measurement: physical examination.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFarzaneh Alamshahi

Ahvaz jundishapur University of Medical Sciences, Vice chancellor for research

info@ajums.ac.ir+98 613336754360

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026